For example, in Alzheimer’s disease, DAM have been characterized by the upregulation of genes such as apolipoprotein E (APOE) and triggering receptor expressed on myeloid cells 2 (TREM2) while downregulating genes involved in synaptic function and homeostasis [64,65]. This evidence concerns the gene TREM2 and early-onset autosomal dominant Alzheimer disease.